(Q46790310)

25 December 2017

title

Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes (English)

1 reference

25 December 2017

0 references

1 reference

3

Riitta Veijola

1 reference

25 December 2017

author name string

Minna Päivärinta

series ordinal

1

1 reference

25 December 2017

Päivi Tapanainen

series ordinal

2

1 reference

25 December 2017

publication date

25 January 2008

1 reference

25 December 2017

published in

Pediatric Diabetes

1 reference

25 December 2017

volume

9

1 reference

25 December 2017

page(s)

83-90

1 reference

25 December 2017

issue

3 Pt 2

1 reference

25 December 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Insulin analogues and their potential in the management of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Therapy with insulin glargine (Lantus) in toddlers, children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Initiation of insulin glargine in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

Insulin glargine: a systematic review of a long-acting insulin analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00341.X

10.1111/J.1399-5448.2007.00341.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18221431

1 reference

25 December 2017